New Horizons – Using Real World Evidence to Impact Future Clinical Trials
Pete Knox of The Life Raft Group presented Using Real World Evidence to Impact Future Clinical Trials and Improve Patient Survival: A Focus on Placebos at New Horizons 2021.
Pete Knox of The Life Raft Group presented Using Real World Evidence to Impact Future Clinical Trials and Improve Patient Survival: A Focus on Placebos at New Horizons 2021.
Every GIST patient (and person in general) is unique, however, there are some common issues that patients may face during their GIST journey.
CTOS 2020 was conducted virtually from November 18th through the 21st, given the nature of our current environment, much of the content of the conference centered on COVID-19 and its impact on cancer patients, but there were a number of sessions and presentations and posters devoted to GIST as well.
As research regarding GIST and other relevant topics is extensive and dynamic, consensus among the Real World Evidence Team was that it would be a good idea to convene a group tasked with monitoring and assessing this research. Recently the LRG held its inaugural virtual meeting of the newly formed LRG Science Forum.
Pete Knox represents The Life Raft Group and GIST patients at ISPOR’s 2019 European Conference, held November 2nd-6th in Copenhagen, Denmark.
The Ottawa GIST Day of Learning (GDOL) was hosted by the Life Raft Group Canada and the LRG's Pete Knox presented on SideEQ virtually.
Symptom and Side Effect Management of GIST Treatment GIST and its treatment can cause a variety of symptoms. Adequate management of symptoms can improve a patient’s quality of life. Proper management can also allow [...]
Originally published in June of 2019, GIST Israel provided Hebrew subtitles for this webcast on Symptom & Side Effect Management.
Ten Tips for Life with a Rare Disease The challenges of living with GIST are many - here are our top ten tips to navigate this journey toward thriving and surviving. 1. Get a [...]
Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.